Abstract:Background Puerarin (Pue) is an isoflavone compound with significant therapeutic effect on cardiovascular diseases, but its poor water solubility and low oral bioavailability limit clinical application. Methods In this study, Pue was prepared into PLGA nanoparticles (Pue-PLGA NPs) by emulsion solvent volatilization method. The morphology, particle size, Zeta potential, X-ray diffraction (XRD), and fourier transform infrared (FTIR) of the NPs were characterized. Additionally, their stability and in vitro release were evaluated. SD rats were orally administered wtih Pue and Pue-PLGA NPs, and a high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was established to determine the concentration of blood samples and to investigate the pharmacokinetic behaviour of Pue and Pue-PLGA NPs in rats. Results The NPs were observed by transmission electron microscopy (TEM) as regular spheroids and uniformly dispersed. The average particle size of the NPs was (167.1±5.26）nm, the Zeta potential was (-29.88±2.46)mV, the encapsulation rate was (83.12 %±4.73 %) and the drug loading capacity was (7.75 %±1.81 %). The results of in vitro release showed that the drug was released slowly and continuously from the NPs, reaching the release platform in 24 h, and the cumulative release amount was (88.55±2.86) %. The pharmacokinetic results showed that the AUC0–24, AUC0-∞, Cmax, Tmax, t1/2, MRT0–24 and MRT0-∞ of Pue-PLGA NPs were 2.196, 1.978, 1.327, 1.5, 1.385, 3.915 and 3.140 times of Pue, respectively. The relative bioavailability was (197.82±25.28) %. Conclusion These results indicated that the prepared nanoparticles had small particle size, high encapsulation rate, drug loading capacity and good slow-release effect, and could significantly improve the oral bioavailability of Pue in rats.

Study on Pharmacokinetics of Ferulic Acid Loaded Liposome- In-Chitosan-microspheres in Rats

[Preparation and in Vitro Drug Release of Ferulic Acid Loaded Chitosan Microspheres Containing Liposomes].

Oral Bioavailability and Lymphatic Transport of Pueraria Flavone-Loaded Self-Emulsifying Drug-Delivery Systems Containing Sodium Taurocholate in Rats.

Pharmacokinetic Study of Ferulic Acid Following Transdermal or Intragastric Administration in Rats

Preparation, Characterization, and Evaluation of Liposomal Ferulic Acid in Vitro and in Vivo

Evaluation of chitosan-ferulic acid microcapsules for sustained drug delivery: Synthesis, characterizations, and release kinetics in vitro

[Preparation and Anti-Oxidative Activity of Liposomal Ferulic Acid].

Enhanced Oral Bioavailability and Tissue Distribution of Ferric Citrate Through Liposomal Encapsulation

Technology Optimization of Sustained-Realeasing Chitosan Microspheres Loaded with Ferulic Acid and Their Drug-Releasing Mechanism

Study on Pharmacokinetics of Emodin Solid Lipid Nanoparticles in Rats

Inducing Sustained Release and Improving Oral Bioavailability of Curcumin Via Chitosan Derivatives-Coated Liposomes.

Study on Distribution of Liposome Nanoparticles Loaded Quercetin in Rats

The Pharmacokinetics of Chelerythrine Solution and Chelerythrine Liposomes after Oral Administration to Rats

Studies on Preparation of Diclofenac Sodium Silk Fibroin-Chitosan Sustained-Release Microsphere and Its Characteristics in Vivo and in Vitro

Preparation of Ferulic Acid Liposomes by Calcium Acetate Gradient Method and Its Evaluation in Vitro

Preparation and Evaluation of Puerarin-loaded PLGA Nanoparticles for Improving Oral Bioavailability in SD Rats

Preparation of Chitosan-Ferulic Acid Conjugate: Structure Characterization and in the Application of Pharmaceuticals.

Study on Pharmacokinetics of Ferulic Acid in Compound Angelica Scinensis Solution Taken in Rabbit

Preparation and Characterization of Liposomes Encapsulating Chitosan Nanoparticles

Pharmacokinetics, Tissue Distribution and Excretion Study of Fluoresceinlabeled PS916 in Rats.

Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles